Short-term high dietary calcium intake during bedrest has no effect on markers of bone turnover in healthy men

Autor: Petra Frings-Meuthen, Martina Heer, Natalie Baecker, Scott M. Smith
Rok vydání: 2009
Předmět:
Zdroj: Nutrition (Burbank, Los Angeles County, Calif.). 26(5)
ISSN: 1873-1244
Popis: Objective Immobilization and space flight are causes of disuse osteoporosis. Increasing calcium intake may counteract this disuse-induced bone loss. Methods We conducted two bedrest experiments (crossover design: bedrest versus ambulatory control) in a metabolic ward, studying the effect of 1000 mg/d of calcium intake (study A, length of intervention 14 d) compared with that of a high calcium intake of 2000 mg/d (study B, 6 d) on markers of bone turnover. Both studies were randomized, controlled studies with the subjects staying under well-controlled environmental conditions (study A, 9 male subjects, age 23.6 ± 3.0 y; study B, 8 male subjects, age 25.5 ± 2.9 y). Blood was drawn to analyze serum calcium, parathyroid hormone, procollagen type I C-terminal propeptide, and bone alkaline phosphatase. Urine (24-h) was collected for analysis of calcium, C-terminal telopeptide of collagen type I, and N-terminal telopeptide of collagen type I. Results In both studies, serum calcium levels remained unchanged. Procollagen type I C-terminal propeptide was lower (P = 0.03) in the bedrest phase than in the ambulatory phase in study A and tended to be lower (P = 0.08) in bedrest in study B, whereas bone alkaline phosphatase was not affected in either study. Urinary calcium excretion was greater during bedrest than during the ambulatory phase (study A, P = 0.005; study B, P = 0.002). C-terminal telopeptide of collagen type I excretion was also greater during bedrest in both studies (study A, P Conclusion Doubling calcium intake to 2000 mg/d does not prevent increased bone resorption induced by bedrest.
Databáze: OpenAIRE